LT2978755T - Naujieji piridino dariniai - Google Patents

Naujieji piridino dariniai

Info

Publication number: LT2978755T
Authority: LT; Lithuania
Prior art keywords: pyridine derivatives; novel pyridine; novel; derivatives; pyridine
Prior art date: 2013-03-26

Application number

LTEP14712287.3T

Other languages

English (en)

Inventor

Olivier GAVELLE

Uwe Grether

Atsushi KIMBARA

Matthias Nettekoven

Stephan Roever

Mark Rogers-Evans

Didier Rombach

Tanja Schulz-Gasch

Original Assignee

F. Hoffmann-La Roche Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-26

Filing date

2014-03-24

Publication date

2018-03-12

2014-03-24 Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag

2018-03-12 Publication of LT2978755T publication Critical patent/LT2978755T/lt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Psychology (AREA)
Emergency Medicine (AREA)
Transplantation (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Vascular Medicine (AREA)

LTEP14712287.3T 2013-03-26 2014-03-24 Naujieji piridino dariniai LT2978755T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP13161176		2013-03-26
PCT/EP2014/055797 WO2014154612A1 (en)	2013-03-26	2014-03-24	Novel pyridine derivatives

Publications (1)

Publication Number	Publication Date
LT2978755T true LT2978755T (lt)	2018-03-12

Family

ID=47913322

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEP14712287.3T LT2978755T (lt)	2013-03-26	2014-03-24	Naujieji piridino dariniai

Country Status (34)

Country	Link
US (2)	US10308659B2 (lt)
EP (1)	EP2978755B1 (lt)
JP (1)	JP6500010B2 (lt)
KR (1)	KR20150135458A (lt)
CN (1)	CN105121436B (lt)
AR (1)	AR095721A1 (lt)
AU (1)	AU2014243190B2 (lt)
BR (1)	BR112015024272A2 (lt)
CA (1)	CA2899168A1 (lt)
CL (1)	CL2015002835A1 (lt)
CR (1)	CR20150440A (lt)
DK (1)	DK2978755T3 (lt)
EA (1)	EA027569B1 (lt)
ES (1)	ES2661737T3 (lt)
HK (1)	HK1211938A1 (lt)
HR (1)	HRP20180371T1 (lt)
HU (1)	HUE036934T2 (lt)
IL (1)	IL240496B (lt)
LT (1)	LT2978755T (lt)
MA (1)	MA38404B1 (lt)
MX (1)	MX365921B (lt)
MY (1)	MY174000A (lt)
NO (1)	NO2978755T3 (lt)
PE (1)	PE20151559A1 (lt)
PH (1)	PH12015501933A1 (lt)
PL (1)	PL2978755T3 (lt)
PT (1)	PT2978755T (lt)
RS (1)	RS56927B1 (lt)
SG (1)	SG11201507994QA (lt)
SI (1)	SI2978755T1 (lt)
TW (1)	TWI628174B (lt)
UA (1)	UA116239C2 (lt)
WO (1)	WO2014154612A1 (lt)
ZA (1)	ZA201505251B (lt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN106536516B (zh) *	2014-06-09	2019-09-03	住友化学株式会社	用于制备吡啶化合物的方法
LT3386951T (lt)	2015-12-09	2020-05-11	F. Hoffmann-La Roche Ag	Fenilo dariniai kaip 2 tipo kanabinoidų receptorių agonistai
PL3481200T3 (pl) *	2016-07-07	2021-05-17	Dow Agrosciences Llc	Sposoby wytwarzania 4-alkoksy-3-(acylo lub alkilo)oksypikolinamidów
TW202334101A (zh) *	2017-04-06	2023-09-01	美商富曼西公司	殺真菌之噁二唑
AR112199A1 (es) *	2017-06-20	2019-10-02	Hoffmann La Roche	Derivados de piridina como agonistas inversos del receptor cannabinoide 2
WO2019003956A1 (ja) *	2017-06-27	2019-01-03	住友化学株式会社	オキサジアゾール化合物及びその用途
CN108774220B (zh) *	2018-05-27	2019-04-23	西安培华学院	用于治疗心肌缺血的化合物及其应用
CN112074513A (zh)	2018-06-27	2020-12-11	豪夫迈·罗氏有限公司	作为优先***素2激动剂的吡啶和吡嗪衍生物
CN114195759B (zh) *	2021-08-26	2023-10-20	上海零诺生物科技有限公司	一种2-甲基-5-（1-甲基吡咯烷-2-基）吡啶制备方法
WO2023069721A2 (en) *	2021-10-22	2023-04-27	Carmot Therapeutics, Inc.	Oxazole, oxadiazole, and indole derivatives for the inhibition of usp28
CN115073366A (zh) *	2022-06-08	2022-09-20	都创(重庆)医药科技有限公司	一种基于微通道技术快速制备3-氯吡啶-2-甲酸的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2479744A1 (en) *	2002-03-28	2003-10-09	Paul E. Finke	Substituted 2,3-diphenyl pyridines
CA2660704A1 (en)	2006-08-07	2008-02-14	Ironwood Pharmaceuticals, Inc.	Indole compounds
WO2009051705A1 (en) *	2007-10-18	2009-04-23	Merck & Co., Inc.	Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
US9321727B2 (en) *	2011-06-10	2016-04-26	Hoffmann-La Roche Inc.	Pyridine derivatives as agonists of the CB2 receptor
UA111640C2 (uk)	2011-11-08	2016-05-25	Ф. Хоффманн-Ля Рош Аг	ПОХІДНІ [1,2,3]ТРИАЗОЛО[4,5-d]ПІРИМІДИНУ ЯК АГОНІСТИ КАНАБІНОЇДНОГО РЕЦЕПТОРА 2
WO2014005968A1 (en)	2012-07-04	2014-01-09	F. Hoffmann-La Roche Ag	Novel adamantyl derivatives as cannabinoid receptor 2 agonists
LT2928882T (lt)	2012-12-07	2017-03-27	F. Hoffmann-La Roche Ag	Pirazino dariniai kaip cb2 receptoriaus agonistai
CN104837818B (zh)	2012-12-07	2017-07-14	霍夫曼-拉罗奇有限公司	可用作cb2激动剂的吡啶‑2‑酰胺
WO2014086705A1 (en)	2012-12-07	2014-06-12	F. Hoffmann-La Roche Ag	Novel pyridine derivatives
US9303012B2 (en)	2012-12-07	2016-04-05	Hoffman-La Roche Inc.	Pyridine-2-amides useful as CB2 agonists
SI2964646T1 (sl)	2013-03-07	2017-08-31	F. Hoffmann-La Roche Ag	Novi derivati pirazola
CA2944256A1 (en)	2014-04-04	2015-10-08	F. Hoffmann-La Roche Ag	5,6-disubstituted pyridine-2-carboxamides as cannabinoid receptor agonists
MX2016012689A (es)	2014-04-04	2016-12-14	Hoffmann La Roche	Piridin-2-amidas utiles como agonistas del receptor 2 cannabinoide (cb2).

2014
- 2014-03-24 JP JP2016504604A patent/JP6500010B2/ja not_active Expired - Fee Related
- 2014-03-24 PT PT147122873T patent/PT2978755T/pt unknown
- 2014-03-24 EP EP14712287.3A patent/EP2978755B1/en not_active Not-in-force
- 2014-03-24 MY MYPI2015703306A patent/MY174000A/en unknown
- 2014-03-24 HU HUE14712287A patent/HUE036934T2/hu unknown
- 2014-03-24 NO NO14712287A patent/NO2978755T3/no unknown
- 2014-03-24 RS RS20180226A patent/RS56927B1/sr unknown
- 2014-03-24 SI SI201430615T patent/SI2978755T1/en unknown
- 2014-03-24 KR KR1020157030611A patent/KR20150135458A/ko not_active Application Discontinuation
- 2014-03-24 WO PCT/EP2014/055797 patent/WO2014154612A1/en active Application Filing
- 2014-03-24 EA EA201591567A patent/EA027569B1/ru not_active IP Right Cessation
- 2014-03-24 UA UAA201510076A patent/UA116239C2/uk unknown
- 2014-03-24 DK DK14712287.3T patent/DK2978755T3/en active
- 2014-03-24 PE PE2015002063A patent/PE20151559A1/es active IP Right Grant
- 2014-03-24 LT LTEP14712287.3T patent/LT2978755T/lt unknown
- 2014-03-24 AU AU2014243190A patent/AU2014243190B2/en not_active Ceased
- 2014-03-24 SG SG11201507994QA patent/SG11201507994QA/en unknown
- 2014-03-24 PL PL14712287T patent/PL2978755T3/pl unknown
- 2014-03-24 MX MX2015013629A patent/MX365921B/es active IP Right Grant
- 2014-03-24 CA CA2899168A patent/CA2899168A1/en not_active Abandoned
- 2014-03-24 ES ES14712287.3T patent/ES2661737T3/es active Active
- 2014-03-24 MA MA38404A patent/MA38404B1/fr unknown
- 2014-03-24 BR BR112015024272A patent/BR112015024272A2/pt not_active Application Discontinuation
- 2014-03-24 CN CN201480017405.4A patent/CN105121436B/zh not_active Expired - Fee Related
- 2014-03-25 TW TW103111118A patent/TWI628174B/zh not_active IP Right Cessation
- 2014-03-25 AR ARP140101336A patent/AR095721A1/es unknown
2015
- 2015-07-21 ZA ZA2015/05251A patent/ZA201505251B/en unknown
- 2015-08-10 IL IL240496A patent/IL240496B/en active IP Right Grant
- 2015-08-25 CR CR20150440A patent/CR20150440A/es unknown
- 2015-09-02 PH PH12015501933A patent/PH12015501933A1/en unknown
- 2015-09-23 CL CL2015002835A patent/CL2015002835A1/es unknown
- 2015-09-28 US US14/868,305 patent/US10308659B2/en not_active Expired - Fee Related
- 2015-12-30 HK HK15112855.2A patent/HK1211938A1/xx not_active IP Right Cessation
2018
- 2018-03-01 HR HRP20180371TT patent/HRP20180371T1/hr unknown
2019
- 2019-04-24 US US16/393,794 patent/US20190248803A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN105121436A (zh)	2015-12-02
MX2015013629A (es)	2016-02-18
PL2978755T3 (pl)	2018-05-30
PE20151559A1 (es)	2015-11-05
AU2014243190B2 (en)	2018-07-19
MX365921B (es)	2019-06-20
SG11201507994QA (en)	2015-10-29
TWI628174B (zh)	2018-07-01
MA38404B1 (fr)	2017-09-29
RS56927B1 (sr)	2018-05-31
DK2978755T3 (en)	2018-03-05
IL240496B (en)	2019-03-31
PH12015501933B1 (en)	2016-01-11
CA2899168A1 (en)	2014-10-02
KR20150135458A (ko)	2015-12-02
US10308659B2 (en)	2019-06-04
UA116239C2 (uk)	2018-02-26
PT2978755T (pt)	2018-02-26
MY174000A (en)	2020-03-03
CN105121436B (zh)	2018-07-27
HK1211938A1 (en)	2016-06-03
AU2014243190A1 (en)	2015-07-30
TW201518287A (zh)	2015-05-16
JP6500010B2 (ja)	2019-04-10
IL240496A0 (en)	2015-09-24
BR112015024272A2 (pt)	2017-07-18
JP2016516737A (ja)	2016-06-09
US20160016968A1 (en)	2016-01-21
EA201591567A1 (ru)	2016-01-29
ES2661737T3 (es)	2018-04-03
ZA201505251B (en)	2016-07-27
CR20150440A (es)	2015-10-08
EA027569B1 (ru)	2017-08-31
PH12015501933A1 (en)	2016-01-11
HRP20180371T1 (hr)	2018-04-06
NO2978755T3 (lt)	2018-06-02
SI2978755T1 (en)	2018-03-30
HUE036934T2 (hu)	2018-08-28
CL2015002835A1 (es)	2016-05-20
EP2978755A1 (en)	2016-02-03
WO2014154612A1 (en)	2014-10-02
MA38404A1 (fr)	2017-01-31
US20190248803A1 (en)	2019-08-15
AR095721A1 (es)	2015-11-04
EP2978755B1 (en)	2018-01-03

Publication	Publication Date	Title
HK1215795A1 (zh)	2016-09-15	鵝膏毒素衍生物
HRP20170919T1 (hr)	2017-09-22	Novi derivati pirazola
SG11201506100XA (en)	2015-09-29	Pyridazinone-amides derivatives
HK1211938A1 (en)	2016-06-03	Novel pyridine derivatives
ZA201507657B (en)	2022-08-31	Pyridin-4-yl derivatives
ZA201601333B (en)	2019-12-18	Oxoquinazolinyl-butanamide derivatives
SG11201605189YA (en)	2016-07-28	Imidazopyrazinone derivatives
HK1213566A1 (zh)	2016-07-08	新的四唑酮衍生物